Menu

Proposed Federal Budget Slashes Funds to EPA, CDC

Funds for the NIH and NSF would stay flat, while some agencies, including the FDA and NASA, would see increases.

Feb 13, 2018
Diana Kwon

PIXABAY, 12019Yesterday (February 12), President Donald Trump’s administration released its proposed budget for fiscal year 2019—just days after Congress passed a deal to increase discretionary spending caps. The proposal calls for cuts to some science agencies, including the Environmental Protection Agency (EPA) and the Centers for Disease Control and Prevention (CDC), while maintaining or boosting funding for others.

Under the proposed budget, funds for the National Science Foundation (NSF) and the National Institutes of Health (NIH) would remain at roughly the same level as in 2017. Trump’s plan also includes adding three new agencies within the NIH, Nature reports: Two existing agencies, the National Institute of Disability, Independent Living, and Rehabilitation Research and the National Institute of Occupational Safety and Health, would be transferred over to the NIH from the Department of Health and Human Services (HHS) and from the CDC, respectively; and a new National Institute for Research on Safety and Quality would replace HHS’s Agency for Healthcare Research and Quality.

“We are. . . concerned that the president’s budget would fold the Agency for Healthcare Research and Quality (AHRQ) into the NIH,” Research!America CEO Mary Woolley says in a statement. “This is a strategic mistake that dilutes the agency’s critical mission to address waste and inefficiencies in our health care system.”

The proposal also aims to shrink the EPA’s budget by approximately 25 percent below the 2017 level. According to Nature, the plan would eliminate funds to climate change research, reorganize existing programs addressing issues such as clean water and land preservation, and allocate funds to two new items, dubbed “core mission” and “Rule of Law and Process.” This change “gives [the administration] carte blanche to do whatever they want,” Dan Costa, former head of the EPA’s air, climate, and energy research program, tells Nature.

The CDC and the Department of Education would also see budget reductions, of 12 percent and 5 percent, respectively.

See “Cuts to Prevention and Public Health Fund Puts CDC Programs at Risk

Other science agencies, such the Food and Drug Administration (FDA) and NASA, would see a growth in funds. The budget would give the FDA $3.3 billion, approximately $460 million more than it received in 2017, and NASA $19.9 billion, or a 1.3 percent increase. The proposal also allocates funds to fighting the opioid crisis, The New York Times reports: The Drug Enforcement Agency would receive an extra $41 million for this purpose and another $43 million would go toward fighting the opioid epidemic in schools.

Whether the proposal will pass through Congress remains to be seen. According to The New York Times, “The blueprint is largely a political statement and is unlikely to influence lawmakers, who control the federal pursestrings.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.